06/12/2025
CLMMRH Pharmacists Excel in Oncology Pharmacy Training
By: Jennifer G. Delfin, RPh
Corazon Locsin Montelibano Memorial Regional Hospital (CLMMRH) proudly recognizes the commendable dedication and performance of its pharmacists: Mr. Chilton R. Montero, RPh, and Ms. Khristine Myro G. Casabuena, RPh, for completing the Oncology Rx Training Program with flying colors, last November 30 to December 3, 2025.
The Oncology Rx Training Program is a three-day intensive course. Its first day commenced with a meaningful hospital tour at Ospital ng Makati. Through the partnership of Shu Ha Ri Training Center, Garrod Specialty Pharmacy, and the Philippine Oncology Pharmacist Practitioners Society (POPPS), participants were given an up-close look at oncology pharmacy operations and the meticulous process behind safe chemotherapy preparation, an experience that emphasized the patient-centered nature of oncology practice.
On December 1, learning continued with essential discussions on cancer pharmacotherapy, hazardous drug handling, and aseptic techniques. These were paired with hands-on exercises designed to strengthen technical skills and build confidence in managing high-risk medications. Training resumed on December 2 with additional modules and guided practice sessions, preparing participants for their final competency assessment.
By December 3, participants performed their return demonstrations, showcasing the knowledge, precision, and safety-focused mindset they had developed throughout the program. The training concluded with the awarding of the “Certificate of Completion: Oncology Rx – A Competency-Based Training on Cancer Pharmacotherapy and Aseptic Oncology Compounding.”
Ms. Casabuena and Mr. Montero’s accomplishment reflects a strong commitment to continuous professional growth and to advancing safe, competent, and compassionate oncology pharmacy practice. This short but meaningful journey strengthened their technical skills, deepened their understanding of oncology pharmacotherapy, and further renewed their commitment to delivering safe and high-quality cancer care.